Showing results (71-80 of 7,385) with videos related to

Sort By:
Pageof 739
The Journal of Biological Chemistry|October 3, 2012
Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entryAndrew P-A Karalewitz, Zhuji Fu, Michael R Baldwin, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidaseKaterina Capková, Mark S Hixon, Sabine Pellett, et al.
Journal of the American Chemical Society|February 18, 2010
Botulinum neurotoxin A protease: discovery of natural product exosite inhibitorsPeter Silhár, Katerina Capková, Nicholas T Salzameda, et al.
Vaccine|August 16, 2011
Subunit vaccine efficacy against Botulinum neurotoxin subtypesJames S Henkel, William H Tepp, Amanda Przedpelski, et al.
Cellular Microbiology|May 11, 2007
Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoSYue Zhang, Qing Deng, Jaclyn A Porath, et al.
Infection and Immunity|October 31, 2007
Recombinant holotoxoid vaccine against botulismChristina L Pier, William H Tepp, Marite Bradshaw, et al.
The Journal of Biological Chemistry|February 1, 2002
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoSMatthew J Riese, Udo-Michael Goehring, Mary E Ehrmantraut, et al.
Biochemistry|September 1, 2012
Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241Nathan C Simon, James M Vergis, Avesta V Ebrahimi, et al.
Plos One|September 24, 2013
Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cellsSusan R Heimer, David J Evans, Michael E Stern, et al.
Pageof 739